BioMed Research International / 2016 / Article / Tab 5

Review Article

Lower Level of Bacteroides in the Gut Microbiota Is Associated with Inflammatory Bowel Disease: A Meta-Analysis

Table 5

(a) Summary of outcomes of included studies with continuous data (method: T-RFLP). (b) Summary of outcomes of included studies with continuous data (method: QPCRΔ). (c) Summary of outcomes of included studies with continuous data (method: conventional culture). (d) Summary of outcomes of included studies with continuous data (method: FISH).
(a)

Standard Mean Difference95% CI value

CD versus control group
0.23(−0.42, 0.88)0.48NA
UC versus control group
0.23(−0.27, 0.73)0.36NA
CD versus UC
−0.11(−0.61, 0.39)0.67NA
UC versus remission UC0.36(−0.33, 1.05)0.30NA
Active UC versus control group
0.44(−0.19, 1.06)0.17NA

CD = Crohn’s disease, UC = ulcerative colitis, IC = indeterminate colitis, and NA = not available; UC: CAI > 5.
(b)

Standard Mean Difference95% CI value

CD versus control group
−1.42(−1.94, −0.19)NA
UC versus control group
−0.77(−1.11, −0.42)NA
CD versus UC
−0.38(−0.85, 0.09)0.12NA
CD versus remission CD−0.60(−1.48, 0.28)NA
UC versus remission UC−0.29(−0.98, −0.09)0.02NA
Active CD versus control group
−1.62(−2.24, −1.01)NA
Active UC versus control group
−0.68(−1.02, −0.35)NA
Remission CD versus control group−0.54(−1.65, 0.15)0.02NA
Remission UC versus control group−0.90(−0.98, −0.09)0.02NA

CD = Crohn’s disease, UC = ulcerative colitis, IC = indeterminate colitis, and NA = not available; CD: CDAI > 150; UC: CAI > 5; Δ: QPCR: Real-Time Quantitative PCR.
(c)

Standard Mean Difference95% CI value

CD versus control group0.47(0.06, 0.89)0.03NA
UC versus control group0.18(−0.18, 0.54)0.32NA
CD versus UC
0.04(−0.28, 0.37)0.78NA
CD versus IC
0.37(0.04, 0.70)0.03NA
UC versus IC
0.13(−0.13, 0.39)0.34NA
IC versus control group0.34(−0.02, 0.71)0.07NA

CD = Crohn’s disease, UC = ulcerative colitis, IC = indeterminate colitis, and NA = not available.
(d)

Standard Mean Difference95% CI value

CD versus control group0.17(−0.6, 0.94)0.67NA
UC versus control group1.01(0.46, 1.57)93% ()
CD versus UC
0.17(−0.60, 0.94)0.66NA
CD versus IC
0.71(0.1, 1.31)0.0294% ()
UC versus IC
0.37(−0.2, 0.95)0.2092% ()
IC versus control group
−0.54(−1.13, 0.06)0.0894% ()

CD = Crohn’s disease, UC = ulcerative colitis, IC = indeterminate colitis, and NA = not available.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.